Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old (NLD3)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00780741|
Recruitment Status : Completed
First Posted : October 28, 2008
Results First Posted : November 12, 2012
Last Update Posted : June 24, 2016
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Nasolacrimal Duct Obstruction
Procedure: Immediate Office Probing
Procedure: Deferred Facility Probing
Between November 2008 and September 2010, 163 participants with unilateral nasolacrimal duct obstruction (NLDO) were enrolled at 22 clinical centers.
During the same period, 57 participants were recruited with bilateral nasolacrimal duct obstruction (NLDO), however, these participants are not included in the analyses reported herein.
Conclusions not definitive--would need larger sample size.
Participants with bilateral NLDO excluded, so results not generalizable to bilateral cases.
Actual costs may vary by region and payer.
Did not include costs of follow up visits.